Back to research

Research paper

ROHHAD (Rapid-onset Obesity with Hypoventilation, Hypothalamic Dysfunction, Autonomic Dysregulation) Syndrome — What Every Pediatrician Should Know About the Etiopathogenesis, Diagnosis and Treatment: A Review

Review of ROHHAD syndrome (Rapid-Onset Obesity, Hypothalamic dysfunction, Hypoventilation, Autonomic Dysregulation). Establishes the core tetrad and the typical age of onset (1.5-7 years). Hypothalamic features include hyperphagia, temperature instability, water-balance dysregulation, and behavioral / mood disturbance. Hypoventilation is the most life-threatening feature. Etiology unknown - possibly autoimmune (anti-ZSCAN1 antibodies in some cases) or paraneoplastic (with neural crest tumors).

Indexed context

Lazea C, et al.

rohhadhypothalamic-syndromehyperphagiatemperature-instabilityautonomic-dysregulationhypoventilationpediatric-endocrinologyreview

Markdown path

content/research/papers/2021-lazea-rohhad-review.md

Findings

Review of ROHHAD syndrome (Rapid-Onset Obesity, Hypothalamic dysfunction, Hypoventilation, Autonomic Dysregulation). Establishes the core tetrad and the typical age of onset (1.5-7 years). Hypothalamic features include hyperphagia, temperature instability, water-balance dysregulation, and behavioral / mood disturbance. Hypoventilation is the most life-threatening feature. Etiology unknown - possibly autoimmune (anti-ZSCAN1 antibodies in some cases) or paraneoplastic (with neural crest tumors).

Why it may matter for Levi

ROHHAD-specific overlap with Levi's hyperphagia + temperature instability + autonomic features is partial - Levi has the hypothalamic features but does not (yet) have rapid-onset obesity or hypoventilation, both of which are core ROHHAD features. Lazea 2021 helps define the differential boundary - useful for ruling ROHHAD as a less-likely-but-not-excluded item in the broader hypothalamic syndrome differential, and establishes the precedent for nocturnal hyperphagia as a hypothalamic phenotype. Indirect but framing-relevant.

Paper text

ROHHAD Syndrome — Etiopathogenesis, Diagnosis, and Treatment Review

Lazea C, Sur L, Florea M — Int J Gen Med (2021). PMID 33542648 · doi:10.2147/IJGM.S293377 · Open-access PDF

Findings summary

Comprehensive pediatric review of Rapid-onset Obesity with Hypoventilation, Hypothalamic dysfunction, and Autonomic Dysregulation (ROHHAD) syndrome. Key points:

  • Rare disease; ~80-100 cases reported by 2021; etiology unknown / debated (paraneoplastic vs. autoimmune vs. genetic hypotheses).
  • Clinical tetrad: rapid-onset obesity in early childhood + central hypoventilation + hypothalamic dysfunction + autonomic dysregulation.
  • Hypothalamic dysfunction features in ROHHAD commonly include: central hypothyroidism, hyperprolactinemia, growth hormone deficiency, ACTH/cortisol deficiency, precocious puberty, hypogonadotropic hypogonadism, water-balance disorders (including SIADH and diabetes insipidus patterns), hyperphagia, temperature instability, altered pain perception, and altered thirst.
  • Autonomic dysregulation: thermal instability, altered pain perception, strabismus, GI dysmotility, sweating abnormalities, pupillary abnormalities.
  • Neural crest tumors (ganglioneuroma, ganglioneuroblastoma, neuroblastoma) occur in roughly 40-50% of ROHHAD cases, giving rise to the "ROHHAD-NET" designation.
  • Diagnosis: clinical. Workup includes polysomnography + end-tidal/transcutaneous CO2, full anterior + posterior pituitary panel, thoracoabdominal imaging (neural crest tumor search), PHOX2B sequencing (to exclude CCHS), autonomic testing.
  • Treatment: supportive; ventilatory support is critical and life-saving; endocrine replacement per deficit; tumor resection when identified; IVIG has been tried with mixed results.
  • Prognosis: high morbidity/mortality, driven by cardiopulmonary arrest from unrecognized hypoventilation; early recognition and ventilatory support dramatically improve outcomes.

Relevance to Levi

High-priority differential to address explicitly. Levi has several overlapping features that place ROHHAD on the differential, even if other features argue against it:

Compatible with ROHHAD:

  • Hyperphagia (present; recently refined to include 1.5-year history of recurrent nocturnal food-seeking).
  • Temperature instability (present).
  • High pain threshold (present).
  • Recurrent constipation (GI dysmotility is a ROHHAD autonomic feature).
  • Symmetric overgrowth with weight on 99th percentile.
  • Disrupted sleep with recurrent nocturnal awakenings.

Arguing against ROHHAD:

  • No history of rapid-onset weight gain — Levi's overgrowth has been symmetric and proportional from ~12 months, not rapid onset in early childhood.
  • No documented central hypoventilation. No polysomnography has specifically evaluated hypoventilation with end-tidal CO2 or transcutaneous CO2.
  • No thoracoabdominal imaging has been done to screen for neural crest tumors.
  • No documented endocrine deficits — but this is because endocrine function has never been tested, not because it was tested and normal.

Key diagnostic gaps that make ROHHAD currently unfalsified:

  • Polysomnography with end-tidal or transcutaneous CO2 monitoring (standard workup; never done).
  • Full anterior and posterior pituitary panel (never done; only TSH/fT4 exist).
  • Thoracoabdominal imaging with attention to the adrenal gland and sympathetic chain (never done).
  • Dedicated sellar MRI (never done).

The evidence strength for Levi having ROHHAD specifically is low given the absence of documented rapid-onset obesity or hypoventilation. But the evidence strength for a ROHHAD-adjacent hypothalamic-dysfunction workup being warranted is moderate-to-strong given the phenotypic overlap on the hypothalamic-signature features. Even if ROHHAD itself is not the answer, the diagnostic workup is highly informative across multiple competing theories on Levi's differential.

Provenance